COVID-19 rapid guideline (updated): managing symptoms (including at the end of life) in the community (NG163)
The guideline has been updated to include a link to support off-label prescribing for patients with breathlessness. Some tables were amended to highlight doses of medicines used for breathlessness, anxiety and delirium may need to be adjusted in some patients.
Source:
National Institute for Health and Care Excellence